Yu Group

Synthesis of advanced functional materials and their applications

Professor Chengzhong (Michael) Yu is an internationally recognised expert in materials science.

His group has focused on the synthesis of functional nanomaterials specifically nanoporous materials and their applications in drug delivery, diagnostics and energy storage.

Professor Yu has over 400 publications, which have been cited over 27,890 times and resulted in an H-index of 87 (Google Scholar).

He is an Australian Research Council (ARC) Future Fellow (2009). He is the recipient of the 2015 Le Févre Memorial Prize for Chemistry (The Australian Academy of Science), 2015 UQ Vice-Chancellor’s Research Focused Fellowship, and 2004 the second prize of the National Science Award of China 2004. He has been invited to give more than 70 plenary, keynote and invited talks. Professor Yu is a referee for more than 60 international journals, and a reviewer for the ARC and NHMRC.



N4 Pharma

N4 Pharma is a drug reformulation company focused on developing and out licensing new versions of existing and novel high value drugs with an unmet commercial or medical need


Elanco Animal Health is a global leader in the discovery and development of products that improve animal health, performance and well-being.


Anpario offers products that work in harmony with the natural aspects of the animal’s biology to promote healthy growth.


Ellume is a health technology company that commercialises quantum dot based diagnostics to enable real-time detection of common conditions, such as influenza, strep throat, and chlamydia.